"Pentetic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Descriptor ID |
D004369
|
MeSH Number(s) |
D02.092.782.590 D02.241.081.018.639
|
Concept/Terms |
Pentetic Acid- Pentetic Acid
- Diethylenetriamine Pentaacetic Acid
- Acid, Diethylenetriamine Pentaacetic
- Pentaacetic Acid, Diethylenetriamine
- Penthanil
- Pentaind
- DETAPAC
- DTPA
Pentetate Calcium Trisodium- Pentetate Calcium Trisodium
- Calcium Trisodium, Pentetate
- Trisodium, Pentetate Calcium
- CaNa-DTPA
- CaNa DTPA
- Calcium Trisodium Pentetate
- Pentetate, Calcium Trisodium
- Trisodium Pentetate, Calcium
- Ca-DTPA
- Ca DTPA
- CaDTPA
|
Below are MeSH descriptors whose meaning is more general than "Pentetic Acid".
Below are MeSH descriptors whose meaning is more specific than "Pentetic Acid".
This graph shows the total number of publications written about "Pentetic Acid" by people in this website by year, and whether "Pentetic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 2 | 4 | 6 |
1996 | 0 | 2 | 2 |
1997 | 2 | 0 | 2 |
1999 | 1 | 0 | 1 |
2001 | 2 | 0 | 2 |
2002 | 0 | 1 | 1 |
2003 | 1 | 2 | 3 |
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2011 | 2 | 1 | 3 |
2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pentetic Acid" by people in Profiles.
-
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution. Nucl Med Biol. 2015 Apr; 42(4):375-80.
-
Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma. Mol Imaging Biol. 2011 Aug; 13(4):721-9.
-
A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol. 2011 Apr; 18(4):961-9.
-
Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study. Contrast Media Mol Imaging. 2011 Jul-Aug; 6(4):289-97.
-
Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors. Ann Nucl Med. 2008 May; 22(4):237-43.
-
Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules. 2007 Nov; 8(11):3422-8.
-
Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch Pathol Lab Med. 2006 Sep; 130(9):1354-7.
-
Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol. 2006 Apr; 33(3):349-58.
-
Convenient solid-phase synthesis of diethylenetriaminepenta-acetic acid (DTPA)- conjugated cyclic RGD peptide analogues. Cancer Biother Radiopharm. 2005 Oct; 20(5):547-56.
-
Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody. Cancer Biother Radiopharm. 2003 Dec; 18(6):931-40.